Canadian developments.  Buprenorphine now approved for the treatment of opiate addiction.
Garmaise
David
D
D002047:Buprenorphine / Q000627:therapeutic use*; D002170:Canada; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*
D009292:Narcotic Antagonists; D002047:Buprenorphine